Who We Are
About Us
The Platform
Septerna is a clinical-stage biotechnology company powered by our proprietary Native Complex Platform™
What we do
Unlocking the full potential of GPCRs to build a deep pipeline of oral small molecule therapies
Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.
Ground-breaking science is at our core
Meet The Leaders
Leadership Team
Jeffrey Finer, MD, PhD
Chief Executive Officer and Co-Founder
Liz Bhatt, MS, MBA
Chief Operating Officer
Samira Shaikhly
Chief People Officer
Jae Kim, MD
Chief Medical Officer
Uwe Klein, PhD
Senior Vice President, Biological Sciences
Daniel Long, DPhil
Senior Vice President, Drug Discovery
Ran Xiao, MBA, CFA
Interim Chief Financial Officer and Vice President of Finance and Business Operations
Meet The Directors
Board of Directors
Jeffrey Finer, MD, PhD
Chief Executive Officer and Co-Founder
Alan Ezekowitz, MD, DPhil
Director
Jeffrey Tong, PhD
Chairman of the Board
Abraham Bassan, MS
Director
Bernard Coulie, M.D., Ph.D., M.B.A.
Director
Jake Simson, PhD
Director
Shalini Sharp, MBA
Director
Meet The Founders
Scientific Founders
Jeffrey Finer, MD, PhD
Chief Executive Officer and Co-Founder
Robert Lefkowitz, MD
Founder
Arthur Christopoulos, PhD
Founder
Patrick Sexton, PhD, DSc
Founder